Relation of Disease Severity with Neutrophil Lymphocyte Ratio and Mean Platelet Volume in Rheumatoid Arthritis
Abstract
Objective: Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by symmetrical erosive synovitis. The neutrophil to lymphocyte ratio (NLR) and mean platelet volume (MPV) have been widely used to determine the severity of inflammation. Objectives: We aimed to investigate NLR and MPV values in RA population further assessing the relation between these indices, inflammatory markers and disease activity scores.
Material and Methods: The present study was performed between March 2012 and March 2013, and designed retrospectively. Total 156 patients of RA were included.
Results: The NLR was higher in active disease group but there was not significant difference between the remission group and active disease group (p: 0.616). Also NLR of low disease activity group, moderate disease activity group and high disease activity group were 1.98±0.71, 2.26±1.04, and 3.11±2.16 respectively. There is significant difference between groups (p: 0.030). The MPV of remission group and active disease group were 8.54±0.78 fl and 8.89±0.99 fl, respectively and there is no significant difference between both groups (p: 0.126). Also the MPV of remission group, low disease activity group, moderate disease activity group and high disease activity group were 9.31±1.09 fl, 8.91±0.98 fl, 8.71±0.97 fl, respectively. Although MPV is reduced in patients with higher disease activity, it was found that there was no significant difference between the groups (p: 0.206).
Conclusions: NLR can be a useful marker to assess disease activity in RA patients. Increased NLR values may indicate increased disease activity. Whereas, there is a need for comprehensive studies to claim that average platelet volume as an indicator of disease severity in RA patients.
Keywords
Neutrophil Lymphocyte Ratio,Mean Platelet Volume,Rheumatoid Arthritis
References
- 1. Kaushik P, Kaushik R. Diagnosis and management of rheumatoid arthritis. The American journal of medicine 2008;121:e7; author reply e9-10.
- 2. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. The Journal of rheumatology 1997;24:1477-85.
- 3. Beckham JC, Caldwell DS, Peterson BL et al. Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. Journal of clinical immunology 1992;12:353-61.
- 4. Bhat T, Teli S, Rijal J et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert review of cardiovascular therapy 2013;11:55-9.5. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Critical reviews in oncology/hematology 2013;88:218-30.
- 6. Ahsen A, Ulu MS, Yuksel S et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 2013;36:1357-62.
- 7. Khode V, Sindhur J, Kanbur D, Ruikar K, Nallulwar S. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. Journal of cardiovascular disease research 2012;3:272-5.
- 8. Kurt M, Onal IK, Sayilir AY et al. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepato-gastroenterology 2012;59:1580-2.
- 9. Yazici S, Yazici M, Erer B et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010;21:122-5.10. Jurcut C, Jurcut R, Caraiola S et al. Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. Romanian journal of internal medicine = Revue roumaine de medecine interne 2010;48:51-5.
- 11. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and rheumatism 1995;38:44-8.
- 12. Balsa A, Carmona L, Gonzalez-Alvaro I et al. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. The Journal of rheumatology 2004;31:40-6.